148 related articles for article (PubMed ID: 1999151)
1. Human growth hormone-variant is a biologically active somatogen and lactogen.
MacLeod JN; Worsley I; Ray J; Friesen HG; Liebhaber SA; Cooke NE
Endocrinology; 1991 Mar; 128(3):1298-302. PubMed ID: 1999151
[TBL] [Abstract][Full Text] [Related]
2. The human placental growth hormone variant is mitogenic for rat lymphoma Nb2 cells.
Nickel BE; Kardami E; Cattini PA
Endocrinology; 1990 Feb; 126(2):971-6. PubMed ID: 2298178
[TBL] [Abstract][Full Text] [Related]
3. Human growth hormone-variant demonstrates a receptor binding profile distinct from that of normal pituitary growth hormone.
Ray J; Okamura H; Kelly PA; Cooke NE; Liebhaber SA
J Biol Chem; 1990 May; 265(14):7939-44. PubMed ID: 2335510
[TBL] [Abstract][Full Text] [Related]
4. Indication of different lactogen and somatogen binding sites in the human growth hormone molecule as probed with monoclonal antibodies.
Strasburger CJ; Binder L; Elberg G; Cohen-Chapnik N; Kohen F; Gertler A
Mol Cell Endocrinol; 1989 Nov; 67(1):55-62. PubMed ID: 2482210
[TBL] [Abstract][Full Text] [Related]
5. Binding of human growth hormone (GH)-variant (placental GH) to GH-binding proteins in human plasma.
Baumann G; Dávila N; Shaw MA; Ray J; Liebhaber SA; Cooke NE
J Clin Endocrinol Metab; 1991 Dec; 73(6):1175-9. PubMed ID: 1955498
[TBL] [Abstract][Full Text] [Related]
6. Alteration in the receptor binding specificity of human growth hormone by genomic exon exchange.
Ray J; Okamura H; Kelly PA; Liebhaber SA; Cooke NE
Mol Endocrinol; 1990 Jan; 4(1):101-7. PubMed ID: 2157972
[TBL] [Abstract][Full Text] [Related]
7. A serum-free medium for culturing lactogen dependent and autonomous NB2 node lymphoma cells.
Walker A; Croze F; Friesen HG
Endocrinology; 1987 Jun; 120(6):2389-97. PubMed ID: 3552636
[TBL] [Abstract][Full Text] [Related]
8. Site-directed mutations of human growth hormone that selectively modify its lactogenic activity and binding properties.
Binder L; Gertler A; Elberg G; Guy R; Vogel T
Mol Endocrinol; 1990 Jul; 4(7):1060-8. PubMed ID: 2178223
[TBL] [Abstract][Full Text] [Related]
9. Human growth hormone: 45-kDa isoform with extraordinarily stable interchain disulfide links has attenuated receptor-binding and cell-proliferative activities.
Bustamante JJ; Grigorian AL; Muñoz J; Aguilar RM; Treviño LR; Martinez AO; Haro LS
Growth Horm IGF Res; 2010 Aug; 20(4):298-304. PubMed ID: 20472479
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of growth hormone bioactivity by zinc in the eluted stain assay system.
Dattani MT; Hindmarsh PC; Brook CG; Robinson IC; Weir T; Marshall NJ
Endocrinology; 1993 Dec; 133(6):2803-8. PubMed ID: 8243307
[TBL] [Abstract][Full Text] [Related]
11. The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells.
Hansen BS; Hjorth S; Welinder BS; Skriver L; De Meyts P
Endocrinology; 1993 Dec; 133(6):2809-17. PubMed ID: 8243308
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific expression and thyroid hormone regulation of the endogenous placental growth hormone variant and chorionic somatomammotropin genes in a human choriocarcinoma cell line.
Nickel BE; Cattini PA
Endocrinology; 1991 May; 128(5):2353-9. PubMed ID: 1708334
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of lactogenic activities of ovine prolactin and human growth hormone (hGH) by a novel form of a modified recombinant hGH.
Gertler A; Shamay A; Cohen N; Ashkenazi A; Friesen HG; Levanon A; Gorecki M; Aviv H; Hadary D; Vogel T
Endocrinology; 1986 Feb; 118(2):720-6. PubMed ID: 2417826
[TBL] [Abstract][Full Text] [Related]
14. 20-kDa placental hGH-V has diminished diabetogenic and lactogenic activities compared with 22-kDa hGH-N while retaining antilipogenic activity.
Vickers MH; Gilmour S; Gertler A; Breier BH; Tunny K; Waters MJ; Gluckman PD
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E629-37. PubMed ID: 19509186
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone maintains its own receptors in rat adipocytes.
Grichting G; Goodman HM
Endocrinology; 1986 Aug; 119(2):847-54. PubMed ID: 3015559
[TBL] [Abstract][Full Text] [Related]
16. N-terminal-truncated recombinant analogs of bovine placental lactogen: interaction with human and rat growth hormone receptors and insulin-like growth factor-I secretion mediated by somatogenic receptors in rat hepatocytes.
Vashdi-Elberg D; Staten NR; Sakal E; Krivi GG; Gertler A
Endocrinology; 1995 Mar; 136(3):1258-66. PubMed ID: 7867580
[TBL] [Abstract][Full Text] [Related]
17. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development.
Handwerger S; Freemark M
J Pediatr Endocrinol Metab; 2000 Apr; 13(4):343-56. PubMed ID: 10776988
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders.
Bozzola M; Zecca M; Locatelli F; Radetti G; Pagani S; Autelli M; Tatò L; Chatelain P
J Endocrinol Invest; 1998 Dec; 21(11):765-70. PubMed ID: 9972677
[TBL] [Abstract][Full Text] [Related]
19. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
[TBL] [Abstract][Full Text] [Related]
20. The measurement of growth hormone bioactivity in patient serum using an eluted stain assay.
Dattani MT; Hindmarsh PC; Pringle PJ; Brook CG; Marshall NJ
J Clin Endocrinol Metab; 1995 Sep; 80(9):2675-83. PubMed ID: 7545696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
